home / stock / jupw / jupw news


JUPW News and Press, Jupiter Wellness Inc. From 07/19/21

Stock Information

Company Name: Jupiter Wellness Inc.
Stock Symbol: JUPW
Market: NASDAQ

Menu

JUPW JUPW Quote JUPW Short JUPW News JUPW Articles JUPW Message Board
Get JUPW Alerts

News, Short Squeeze, Breakout and More Instantly...

JUPW - Jupiter Wellness inks multi-year distribution deal with Rigour International

Jupiter Wellness ([[JUPW]] -0.2%) announces a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter Wellness Products within the Mainland of China and non-exclusive distributor for Hong Kong, Korea and South East Asian markets. Under t...

JUPW - Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia

JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter Wellness Products within the Mainland of China and non-exclusive distributor for Hong K...

JUPW - Jupiter Wellness Announces Appointment of Dr. Andy Goren to Scientific Advisory Board

JUPITER, FL / ACCESSWIRE / July 15, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board. Dr. Andy Goren has more than twenty years of experience in clinical research, development, and commercialization of br...

JUPW - Jupiter Wellness launches trial comparing JW-100 and Eucrisa for treatment of eczema

Jupiter Wellness (JUPW) announces a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of patients with mild to moderate eczema (Atopic Dermatitis).Eucrisa is an FDA-approved topical non-steroidal lotion containing crisaborole approved for treatm...

JUPW - Jupiter Wellness Announces initiation of Head-to-Head Trial Comparing JW-100 and Eucrisa(R) for the Treatment of Mild-to-Moderate Eczema

JUPITER, FL / ACCESSWIRE / July 13, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of patients with mild to moderate eczema (Atopic Dermatitis). Eucrisa is an FDA-approved to...

JUPW - Jupiter Wellness shares rise after inking exclusive license agreement for Photocil

Jupiter Wellness (JUPW) has entered into an exclusive agreement with Applied Biology to license Photocil, a topical cream that provides relief for Psoriasis, Vitiligo and Atopic Dermatitis.Shares up nearly 7% premarket.Under the terms of the agreement, Jupiter Wellnes...

JUPW - Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis

*Photo-Therapy in a tub JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW) , today announced they have entered into an exclusive agreement to license Photocil™, a novel patented topical cream that provides clinically-proven relief for Psoriasis, Vit...

JUPW - Jupiter Wellnes announces peer-reviewed publication of atopic dermatitis study results

Jupiter Wellness (JUPW) is trading marginally higher after the company announced the publication of clinical study results for JW-100 lotion containing CBD and aspartame for the treatment of atopic dermatitis ((AD)).The changes in AD (eczema) after 14 days of the application of the ...

JUPW - Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published

https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , today announced the publication of clinical study results to investigate the safety and efficacy of JW-100 its proprietary lotion formulation for the treatm...

JUPW - Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis

JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW) , today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact Dermatitis. The Agreement signed with the Oklahoma Medical Research Foundation is for a licen...

Previous 10 Next 10